Skip to main content
Fig. 3 | BMC Urology

Fig. 3

From: Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer

Fig. 3

Comparison of LOX immunoreactivity score in prostate epithelial cells of benign and malignant patients. BPH, nodular prostate hyperplasia; EP, extra prostatic disease; OC, organ-confined disease. LOX, lysyl oxidase; IRS, immunoreactivity score. Kruskall-Wallis followed by Mann–Whitney non-parametric tests were used to calculate differences between prostatic pathologies

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us